STOCK TITAN

Insulet Corp - PODD STOCK NEWS

Welcome to our dedicated page for Insulet news (Ticker: PODD), a resource for investors and traders seeking the latest updates and insights on Insulet stock.

Insulet Corporation (PODD) delivers innovative diabetes management solutions through its flagship Omnipod® insulin pump system. This page aggregates official news and developments about the company's medical device innovations, financial performance, and strategic initiatives.

Investors and healthcare professionals will find timely updates including quarterly earnings reports, product launch announcements, regulatory milestones, and partnership agreements. All content is sourced directly from verified corporate communications to ensure accuracy.

Key coverage areas include FDA clearances for new devices, clinical study results, international market entries, and technology partnerships enhancing insulin delivery systems. The resource is particularly valuable for tracking advancements in tubeless pump technology and automated insulin dosing integrations.

Bookmark this page for streamlined access to Insulet's latest developments in diabetes care innovation. Check regularly for updates that may impact long-term growth strategies or patient care standards.

Rhea-AI Summary

Insulet Corporation (NASDAQ: PODD) reported financial results for 2020, achieving revenues of $904.4 million, a 22.5% increase from the previous year. The Omnipod System generated $834.9 million in revenue, with U.S. sales rising 25.3%. However, the gross margin decreased to 64.4%, and net income fell to $6.8 million, down from $11.6 million in 2019. For 2021, the company forecasts revenue growth of 15% to 20%. Strategic highlights include the completion of the pivotal study for the Omnipod 5, set for commercial launch in 2021.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.62%
Tags
none
-
Rhea-AI Summary

Insulet Corporation (NASDAQ: PODD), a leader in tubeless insulin pump technology, announced participation in three virtual investor conferences. Key dates include:

  • Citi 2021 Healthcare Conference: February 25, 2021, at 9:50 AM ET
  • Raymond James 42nd Annual Conference: March 1, 2021, at 8:20 AM ET
  • Cowen 41st Annual Conference: March 2, 2021, at 9:10 AM ET

Live audio webcasts will be available on their investor site, with replays post-conference.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.41%
Tags
conferences
-
Rhea-AI Summary

Insulet Corporation (NASDAQ: PODD) has announced the launch of the Omnipod DASH Insulin Management System in Canada. The Omnipod DASH features a touchscreen Personal Diabetes Manager (PDM) that wirelessly controls a tubeless, waterproof Pod, offering up to 72 hours of continuous insulin delivery. Insulet plans a province-by-province rollout throughout 2021, aligning with provincial health program reimbursements. Feedback from early users highlights the system's ease of use and potential for more effective diabetes management.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary

Insulet Corporation (NASDAQ: PODD) announced it will release its financial results for Q4 and the full year of 2020 on February 23, 2021, after the market closes. A conference call will follow at 4:30 p.m. ET to discuss these results. Insulet is known for its innovative Omnipod Insulin Management System, a tubeless insulin pump designed to enhance diabetes management with its simple and wearable technology, allowing up to three days of continuous insulin delivery without needles.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.18%
Tags
-
Rhea-AI Summary

Insulet Corporation (NASDAQ: PODD) will present at the 39th Annual J.P. Morgan Virtual Healthcare Conference on January 12, 2021, at 9:10 a.m. Eastern Time. This event highlights Insulet's innovative Omnipod Insulin Management System, a tubeless insulin pump designed to simplify diabetes management. The system offers up to three days of continuous insulin delivery without the need for needles. A live audio webcast will be available, with a replay accessible post-event. For more information, visit www.insulet.com.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.35%
Tags
conferences
-
Rhea-AI Summary

Insulet Corporation (NASDAQ: PODD), a leader in tubeless insulin pump technology, will present at three virtual investor conferences. The events include the Canaccord Genuity 2020 MedTech & Diagnostics Forum on November 19, the Piper Sandler 32nd Annual Healthcare Conference on November 23, and the Nasdaq 43rd Investor Conference on December 2. Live audio webcasts of the presentations will be available on the Insulet investor website, with replays following each event.

Insulet aims to simplify diabetes management through its Omnipod Insulin Management System.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.83%
Tags
conferences
Rhea-AI Summary

Insulet Corporation (NASDAQ: PODD) reported strong financial results for Q3 2020, with revenue reaching $234.0 million, a 21.8% increase from the previous year, exceeding guidance of 13% to 15%. Total Omnipod revenue was $212.1 million, a 19.7% increase. The company achieved a gross margin of 64.9% and net income of $11.6 million, significantly higher than $0.8 million in Q3 2019. Insulet raised its full-year revenue outlook to 20% to 21% growth, with plans for the commercial launch of Omnipod 5 in early 2021.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.48%
Tags
none
-
Rhea-AI Summary

Insulet Corporation (NASDAQ: PODD) announces its initiatives for Diabetes Awareness Month in November. The company aims to highlight inspiring stories of individuals with diabetes through a campaign called “YESvember.” It will also honor its 20th anniversary by ringing the Nasdaq closing bell on November 9, 2023. Insulet is committed to supporting diabetes research by participating in the JDRF One Walk to raise funds and awareness. The events focus on empowering those with diabetes and acknowledging healthcare providers in their efforts.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.83%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.14%
Tags
none
Rhea-AI Summary

Insulet Corporation (NASDAQ: PODD) announced the appointment of Dr. Wayne A. I. Frederick to its Board of Directors, effective immediately. Dr. Frederick, who is the president of Howard University, brings extensive experience in healthcare disparities, surgery, and medical education. He will also serve on the Board's Audit Committee. The company’s chairman expressed confidence that Dr. Frederick's expertise will significantly benefit Insulet’s global strategic growth initiatives, particularly in advancing its tubeless insulin pump technology.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.91%
Tags
management
Insulet Corp

Nasdaq:PODD

PODD Rankings

PODD Stock Data

17.33B
69.72M
0.38%
102.96%
4.09%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
ACTON